the concept that exposure in utero to maternal anti-brain antibodies contributes to the development of autism spectrum disorders (ASD) has been entertained for over a decade. We determined that antibodies targeting Caspr2 are present at high frequency in mothers with brain-reactive serology and a child with ASD, and further demonstrated that exposure in utero to a monoclonal anti-Caspr2 antibody, derived from a mother of an ASD child, led to an-ASD like phenotype in male offspring. Now we propose a new model to study the effects of in utero exposure to anti-Caspr2 antibody. Dams immunized with the extracellular portion of Caspr2 express anti-Caspr2 antibodies throughout gestation to better mimic the human condition. Male but not female mice born to dams harboring polyclonal anti-Caspr2 antibodies showed abnormal cortical development, decreased dendritic complexity of excitatory neurons and reduced numbers of inhibitory neurons in the hippocampus, as well as repetitive behaviors and impairments in novelty interest in the social preference test as adults. These data supporting the pathogenicity of anti-Caspr2 antibodies are consistent with the concept that anti-brain antibodies present in women during gestation can alter fetal brain development, and confirm that males are peculiarly susceptible. Autism spectrum disorder (ASD) affects 1 in every 58 children in the United States, and is 4 times more prevalent in boys than girls 1. ASD is diagnosed based on the presence of stereotypic behaviors and impairments in social skills and communication. Recent research has emphasized the importance of the in utero environment as a contributing risk factor for ASD. An elegant study demonstrated that siblings born within inter-birth interval of 18 months or less after the birth of a child with ASD have a higher risk for ASD than siblings born after an interval of 4 years or longer time period 2. Moreover, maternal half siblings of a child with ASD are more at risk for ASD than paternal half siblings 2. Several studies looking into maternal risk factors for having a child with ASD have highlighted the importance of infection 3-5 , microbiome 6-8 , and brain-reactive antibodies 9,10. For instance, women with autoimmune diseases such as rheumatoid arthritis (RA), celiac disease or systemic lupus erythematous (SLE) have an increased risk for a child with ASD 11,12. This association holds if the mother (but not the father) exhibits the autoimmune disease.